Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ratjen

Showing results (31-40 of 385) with videos related to

Pageof 39
Sort By:
Clinical Reviews in Allergy & Immunology|November 7, 2006
Beta2-agonists for asthma: the pediatric perspectivePadmaja Subbarao, Felix Ratjen
Annals of the American Thoracic Society|November 24, 2015
Pulmonary Exacerbations in Children with Cystic FibrosisValerie Waters, Felix Ratjen
Expert Review of Respiratory Medicine|June 3, 2014
Inhaled liposomal amikacinValerie Waters, Felix Ratjen
The Lancet. Respiratory Medicine|January 17, 2014
Early lung disease in cystic fibrosisHartmut Grasemann, Felix Ratjen
The Lancet. Respiratory Medicine|February 26, 2023
A new triple combination cystic fibrosis transmembrane regulator modulatorLucy Perrem, Felix Ratjen
Lancet (London, England)|September 12, 2023
Are we there yet? The ongoing journey of cystic fibrosis careLucy Perrem, Felix Ratjen
The Cochrane Database of Systematic Reviews|December 4, 2014
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisValerie Waters, Felix Ratjen
Frontiers in Pharmacology|October 5, 2020
Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic FibrosisLucy Perrem, Felix Ratjen
Lancet (London, England)|February 28, 2003
Cystic fibrosisFelix Ratjen, Gerd Döring
American Journal of Respiratory and Critical Care Medicine|December 4, 2008
Amiloride: still a viable treatment option in cystic fibrosis?Felix Ratjen, Andrew Bush
Pageof 39

Showing results (31-40 of 385) with videos related to

Sort By:
Pageof 39
Clinical Reviews in Allergy & Immunology|November 7, 2006
Beta2-agonists for asthma: the pediatric perspectivePadmaja Subbarao, Felix Ratjen
Annals of the American Thoracic Society|November 24, 2015
Pulmonary Exacerbations in Children with Cystic FibrosisValerie Waters, Felix Ratjen
Expert Review of Respiratory Medicine|June 3, 2014
Inhaled liposomal amikacinValerie Waters, Felix Ratjen
The Lancet. Respiratory Medicine|January 17, 2014
Early lung disease in cystic fibrosisHartmut Grasemann, Felix Ratjen
The Lancet. Respiratory Medicine|February 26, 2023
A new triple combination cystic fibrosis transmembrane regulator modulatorLucy Perrem, Felix Ratjen
Lancet (London, England)|September 12, 2023
Are we there yet? The ongoing journey of cystic fibrosis careLucy Perrem, Felix Ratjen
The Cochrane Database of Systematic Reviews|December 4, 2014
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisValerie Waters, Felix Ratjen
Frontiers in Pharmacology|October 5, 2020
Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic FibrosisLucy Perrem, Felix Ratjen
Lancet (London, England)|February 28, 2003
Cystic fibrosisFelix Ratjen, Gerd Döring
American Journal of Respiratory and Critical Care Medicine|December 4, 2008
Amiloride: still a viable treatment option in cystic fibrosis?Felix Ratjen, Andrew Bush
Pageof 39